Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar 29:3:64.
doi: 10.3389/fimmu.2012.00064. eCollection 2012.

Pathogenic CD8 T cells in multiple sclerosis and its experimental models

Eric S Huseby  1 , Priya G Huseby, Shivanee Shah, Rebecca Smith, Brian D Stadinski
Affiliations

Pathogenic CD8 T cells in multiple sclerosis and its experimental models

Eric S Huseby et al. Front Immunol. .

Abstract

A growing body of evidence suggests that autoreactive CD8 T cells contribute to the disease process in multiple sclerosis (MS). Lymphocytes in MS plaques are biased toward the CD8 lineage, and MS patients harbor CD8 T cells specific for multiple central nervous system (CNS) antigens. Currently, there are relatively few experimental model systems available to study these pathogenic CD8 T cells in vivo. However, the few studies that have been done characterizing the mechanisms used by CD8 T cells to induce CNS autoimmunity indicate that several of the paradigms of how CD4 T cells mediate CNS autoimmunity do not hold true for CD8 T cells or for patients with MS. Thus, myelin-specific CD4 T cells are likely to be one of several important mechanisms that drive CNS disease in MS patients. The focus of this review is to highlight the current models of pathogenic CNS-reactive CD8 T cells and the molecular mechanisms these lymphocytes use when causing CNS inflammation and damage. Understanding how CNS-reactive CD8 T cells escape tolerance induction and induce CNS autoimmunity is critical to our ability to propose and test new therapies for MS.

Keywords: MHC; T cells; TCR; autoimmunity; central nervous system; experimental autoimmune encephalomyelitis; multiple sclerosis; tolerance.

PubMed Disclaimer

References

    1. Abromson-Leeman S., Ladell D. S., Bronson R. T., Dorf M. E. (2007). Heterogeneity of EAE mediated by multiple distinct T-effector subsets. J. Neuroimmunol. 192, 3–1210.1016/j.jneuroim.2007.09.031 - DOI - PMC - PubMed
    1. Antel J. P., Bania M. B., Reder A., Cashman N. (1986). Activated suppressor cell dysfunction in progressive multiple sclerosis. J. Immunol. 137, 137–141 - PubMed
    1. Babbe H., Roers A., Waisman A., Lassmann H., Goebels N., Hohlfeld R., Friese M., Schroder R., Deckert M., Schmidt S., Ravid R., Rajewsky K. (2000). Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192, 393–40410.1084/jem.192.3.393 - DOI - PMC - PubMed
    1. Becher B., Bechmann I., Greter M. (2006). Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J. Mol. Med. 84, 532–54310.1007/s00109-006-0065-1 - DOI - PubMed
    1. Berthelot L., Laplaud D. A., Pettre S., Ballet C., Michel L., Hillion S., Braudeau C., Connan F., Lefrere F., Wiertlewski S., Guillet J. G., Brouard S., Choppin J., Soulillou J. P. (2008). Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals. Eur. J. Immunol. 38, 1889–189910.1002/eji.200838023 - DOI - PubMed